Skip to main content

Brant Allen Inman, MD, MS

Cary N. Robertson, MD, Associate Professor
Associate Professor of Surgery
Office: 3007 Snyderman Bldg, 905 La Salle Street, Durham, NC 27710
Campus Mail: DUMC DUMC Box 103868, Durham, NC 27710

Clinical research interests:
Clinical trials of novel diagnostic tests and therapies for genitourinary malignancies, with a strong focus on bladder cancer.

Basic science research interests:
Immune therapies for cancer, hyperthermia and heat-based treatment of cancer, molecular biology of genitourinary cancers, novel diagnostics and therapies for genitourinary cancers

Education and Training

  • Fellowship, Urologic Oncology, Mayo Clinic, 2005 - 2008
  • Residency, Urology, Universite Laval (Canada), 2001 - 2005
  • M.S., Mayo Clinic, Alix School of Medicine, 2011
  • M.D., University of Alberta (Canada), 2000
  • B.S., University of Alberta (Canada), 1999

Selected Grants


Tan, Wei Phin, Gregory John Barton, Andrew Chang, Smita Nair, and Brant Allen Inman. “Sipuleucel-T to modify the B7-H3 immune checkpoint in men with castrate resistant prostate cancer.” In Journal of Clinical Oncology, 37:273–273. American Society of Clinical Oncology (ASCO), 2019.

Full Text

Dunkman, W Jonathan, Michael W. Manning, John Whittle, John Hunting, Edward N. Rampersaud, Brant A. Inman, Julie K. Thacker, and Timothy E. Miller. “Impact of an enhanced recovery pathway on length of stay and complications in elective radical cystectomy: a before and after cohort study.” Perioper Med (Lond) 8 (2019): 9.

Full Text

Soria, Francesco, Laura-Maria Krabbe, Tilman Todenhöfer, Jakub Dobruch, Anirban P. Mitra, Brant A. Inman, Kilian M. Gust, Yair Lotan, and Shahrokh F. Shariat. “Molecular markers in bladder cancer.” World J Urol 37, no. 1 (January 2019): 31–40.

Full Text

Terlecki, R. P., N. L. Miller, and B. A. Inman. “Trends in Urological Referral Patterns: A Study of Community and University Urologists in the United States.” Urology Practice 5, no. 6 (November 1, 2018): 480–88.

Full Text

Ingersoll, Molly A., Xue Li, Brant A. Inman, John W. Greiner, Peter C. Black, and Rosalyn M. Adam. “Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer.” Bladder Cancer 4, no. 4 (October 29, 2018): 429–40.

Full Text

Gopalakrishna, Ajay, Andrew Chang, Thomas A. Longo, Joseph J. Fantony, Michael R. Harrison, Paul E. Wischmeyer, and Brant A. Inman. “Dietary patterns and health-related quality of life in bladder cancer survivors.” Urol Oncol 36, no. 10 (October 2018): 469.e21-469.e29.

Full Text

Flaig, Thomas W., Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Tracy M. Downs, et al. “NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.” J Natl Compr Canc Netw 16, no. 9 (September 2018): 1041–53.

Full Text

Liu, Yang, Paolo Maccarini, Gregory M. Palmer, Brant A. Inman, and Tuan Vo-Dinh. “Abstract 4152: Synergistic gold nanostar-mediated photothermal and immunotherapy for cancer metastasis treatment.” In Tumor Biology. American Association for Cancer Research, 2018.

Full Text

Liem, Esmee I. M. L., Michael McCormack, Eddie S. Y. Chan, Yoshiyuki Matsui, Petrisor Geavlete, Young D. Choi, Theo M. de Reijke, et al. “Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial.” Urol Oncol 36, no. 7 (July 2018): 338.e1-338.e11.

Full Text

Aminsharifi, Alireza, Steven C. Brousell, Andrew Chang, Juan León, and Brant A. Inman. “Heat-targeted drug delivery: A promising approach for organsparing treatment of bladder cancer.THERMODOX®.” Arch Esp Urol 71, no. 4 (May 2018): 447–52.